Covered recipient · General Payments record
BECKY MCGILLIGAN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,563.98
- Reported across 106 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $270.77 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $211.84 | 16 |
| Axsome Therapeutics, Inc. | $27.53 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $15.81 | 1 |
| Lilly USA, LLC | $15.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | $15.81 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147020429 | CMS |
| Axsome Therapeutics, Inc. | $27.53 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148266809 | CMS |
| Lilly USA, LLC | $15.59 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136063758 | CMS |
| Novo Nordisk Inc | $18.56 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096694304 | CMS |
| Novo Nordisk Inc | $6.91 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097705613 | CMS |
| Novo Nordisk Inc | $12.55 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097087887 | CMS |
| Novo Nordisk Inc | $14.23 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096944129 | CMS |
| Novo Nordisk Inc | $4.68 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096906621 | CMS |
| Novo Nordisk Inc | $11.62 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096776055 | CMS |
| Novo Nordisk Inc | $14.60 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097299573 | CMS |
| Novo Nordisk Inc | $9.82 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097392598 | CMS |
| Novo Nordisk Inc | $11.10 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097510412 | CMS |
| Novo Nordisk Inc | $4.28 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097127960 | CMS |
| Novo Nordisk Inc | $22.52 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097371946 | CMS |
| Novo Nordisk Inc | $10.77 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097299661 | CMS |
| Novo Nordisk Inc | $3.97 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096884627 | CMS |
| Novo Nordisk Inc | $26.30 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097824025 | CMS |
| Novo Nordisk Inc | $16.81 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097382582 | CMS |
| Novo Nordisk Inc | $23.12 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097823907 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.